UBS Group’s ProShares Ultra NVDA NVDB Stock Holding History

UBS Group’s Portfolio NVDB Stock Details NVDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7K	Sell	701 -2,705	-79%	-$83.7K	﹤0.01%	8173
2026 Q1	$77.9K	Buy	3,406 +2,464	+262%	+$65.1K	﹤0.01%	7118
2025 Q4	$26.5K	Buy	+942	New	+$27.4K	﹤0.01%	7595

Other funds holding NVDB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

UBS Group's NVDB Position: Q2 2026 in Review

UBS Group reduced its ProShares Ultra NVDA (NVDB) stake by 79% in Q2 2026, selling an estimated $83.7K and leaving 701 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #8173.

UBS Group first reported a position in NVDB in Q4 2025 and has held it in 3 quarters since. The position peaked at $77.9K in Q1 2026. 4 funds tracked by Wall St. Rank hold NVDB as of Q2 2026.

UBS Group held 701 shares of ProShares Ultra NVDA worth $19.7K as of Q2 2026.
UBS Group sold 2,705 ProShares Ultra NVDA shares in Q2 2026, an estimated $83.7K.
ProShares Ultra NVDA made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8173 holding.
UBS Group first reported a position in ProShares Ultra NVDA in Q4 2025 and has held it in 3 quarters since.
UBS Group's ProShares Ultra NVDA position peaked at $77.9K in Q1 2026.
4 funds tracked by Wall St. Rank held ProShares Ultra NVDA as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.